Infanrix IPV/Hib

Diphtheria, Tetanus, Acellular Pertussis, Inactivated Poliovirus, Haemophilus influenzae type b vaccine (DTaP-IPV-Hib) · GlaxoSmithKline

Drug timelines are a Plus or Pro feature.

8 regulatory and trial events tracked for Infanrix IPV/Hib, covering 2011-06-15 to 2017-12-26. Get the full timeline:

Most recent: Clinical Trial Update: Evaluation of Immunogenicity and Safety of DTPa-IPV/Hib Conjugate Vaccine (Infanrix™-IPV/Hib) Administered at 6, 10 and 14 Weeks in Healthy Indian Infants [Phase 3]

See pricing